The natural history of lung function after lung transplantation for α1-antitrypsin deficiency

American Journal of Respiratory and Critical Care Medicine

Volumn 190, Issue 3, 2014, Pages 274-281

  Banga, Amit ^a   Gildea, Thomas ^a   Rajeswaran, Jeevanantham ^a   Rokadia, Haala ^a   Blackstone, Eugene H ^a   Stoller, James K ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

FEV1 slope; Lung transplantation; Mixed modeling; 1 antitrypsin deficiency

Indexed keywords

ALPHA 1 ANTITRYPSIN; CORTICOSTEROID; IMMUNOGLOBULIN G ANTIBODY; METHYLPREDNISOLONE;

ACUTE GRAFT REJECTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; BRONCHOSCOPY; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPARATIVE STUDY; CORTICOSTEROID THERAPY; FORCED EXPIRATORY VOLUME; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG LAVAGE; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; PATIENT CARE; PRIORITY JOURNAL; SPIROMETRY; TRANSBRONCHIAL BIOPSY; ADULT; FEMALE; FEV1 SLOPE; GENETICS; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MIXED MODELING; MORTALITY; OUTCOME ASSESSMENT; PATHOPHYSIOLOGY; RETROSPECTIVE STUDY; STATISTICS; UNITED STATES; Α1-ANTITRYPSIN DEFICIENCY;

FEV1 SLOPE; LUNG TRANSPLANTATION; MIXED MODELING; Α1-ANTITRYPSIN DEFICIENCY;

ADULT; ALPHA 1-ANTITRYPSIN DEFICIENCY; BRONCHOSCOPY; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; OHIO; OUTCOME ASSESSMENT (HEALTH CARE); PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES; SPIROMETRY;

EID: 84907287137     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201401-0031OC     Document Type: Article

References (27)

1. Tobin MJ, Cook PJ, Hutchison DC. Alpha 1 antitrypsin deficiency: the clinical and physiological features of pulmonary emphysema in subjects homozygous for Pi type Z. A survey by the British Thoracic Association. Br J Dis Chest 1983;77:14-27.
2. Mayer AS, Stoller JK, Vedal S, Ruttenber AJ, Strand M, Sandhaus RA, Newman LS. Risk factors for symptom onset in PI∗Z alpha-1 antitrypsin deficiency. Int J Chron Obstruct Pulmon Dis 2006;1: 485-492.
3. Smith BM, Austin JH, Newell JD Jr, D'Souza BM, Rozenshtein A, Hoffman EA, Ahmed F, Barr RG. Pulmonary emphysema subtypes on computed tomography: the MESA COPD study. Am J Med 2014;127: 94.e7-e23.
4. Seersholm N, Kok-Jensen A. Survival in relation to lung function and smoking cessation in patients with severe hereditary alpha 1-antitrypsin deficiency. Am J Respir Crit Care Med 1995;151:369-373.
5. Stockley RA. a1-antitrypsin deficiency: what has it ever done for us? Chest 2013;144:1923-1929.
6. Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Rahmel AO, Stehlik J, Hertz MI; International Society of Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: 29th adult lung and heart-lung transplant report-2012. J Heart Lung Transplant 2012;31:1073-1086.
7. Hertz MI, Aurora P, Christie JD, Dobbels F, Edwards LB, Kirk R, Kucheryavaya AY, Rahmel AO, Rowe AW, Taylor DO. Registry of the International Society for Heart and Lung Transplantation: a quarter century of thoracic transplantation. J Heart Lung Transplant 2008;27: 937-942.
8. King MB, Campbell EJ, Gray BH, Hertz MI. The proteinaseantiproteinase balance in alpha-1-proteinase inhibitor-deficient lung transplant recipients. Am J Respir Crit Care Med 1994;149:966-971.
9. Meyer KC, Nunley DR, Dauber JH, Iacono AT, Keenan RJ, Cornwell RD, Love RB. Neutrophils, unopposed neutrophil elastase, and alpha1-antiprotease defenses following human lung transplantation. Am J Respir Crit Care Med 2001;164:97-102.
10. Gildea TR, Hammel JP, Stoller JK. Rejection in alpha-1 antitrypsin deficient lung transplantation recipients. Am J Respir Crit Care Med 2007;175:A741.
11. American Thoracic Society. Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995;152:1107-1136.
12. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, et al. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant 2007;26: 1229-1242.
13. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general U.S. population. Am J Respir Crit Care Med 1999;159:179-187.
14. Mason DP, Rajeswaran J, Murthy SC, McNeill AM, Budev MM, Mehta AC, Pettersson GB, Blackstone EH. Spirometry after transplantation: how much better are two lungs than one? Ann Thorac Surg 2008;85: 1193-1201, e1-e2.
15. Diggle PJ, Heagerty P, Liang KY, Zeger SL. Analysis of longitudinal data. 2nd ed. New York: Oxford University Press; 2002.
16. Blackstone EH. Breaking down barriers: helpful breakthrough statistical methods you need to understand better. J Thorac Cardiovasc Surg 2001;122:430-439.
17. Blackstone EH, Naftel DC, Turner ME Jr. The decomposition of timevarying hazard into phases, each incorporating a separate stream of concomitant information. J Am Stat Assoc 1986;81:615-624.
18. Breiman L. Bagging predictors. Mach Learn 1996;24:123-140.
19. Sauerbrei W, Schumacher M. A bootstrap resampling procedure for model building: application to the Cox regression model. Stat Med 1992;11:2093-2109.
20. Little RJA, Rubin DB. Statistical analysis with missing data. New York: Wiley; 1987.
21. Rubin DB. Multiple imputation for non-response in surveys. New York: Wiley; 1997.
22. Wencker M, Fuhrmann B, Banik N, Konietzko N; Wissenschaftliche Arbeitsgemeinschaft zur Therapie von Lungenerkrankungen. Longitudinal follow-up of patients with alpha(1)-protease inhibitor deficiency before and during therapy with IV alpha(1)-protease inhibitor. Chest 2001;119:737-744.
23. Tonelli AR, Rouhani F, Li N, Schreck P, Brantly ML. Alpha-1-antitrypsin augmentation therapy in deficient individuals enrolled in the Alpha-1 Foundation DNA and Tissue Bank. Int J Chron Obstruct Pulmon Dis 2009;4:443-452.
24. Dirksen A, Dijkman JH, Madsen F, Stoel B, Hutchison DC, Ulrik CS, Skovgaard LT, Kok-Jensen A, Rudolphus A, Seersholm N, et al. A randomized clinical trial of alpha(1)-antitrypsin augmentation therapy. Am J Respir Crit Care Med 1999;160:1468-1472.
25. Hubbard RC, Sellers S, Czerski D, Stephens L, Crystal RG. Biochemical efficacy and safety of monthly augmentation therapy for alpha 1-antitrypsin deficiency. JAMA 1988;260:1259-1264.
26. Walker AM. Confounding by indication. Epidemiology 1996;7:335-336.
27. Yusen RD, Christie JD, Edwards LB, Kucheryavaya AY, Benden C, Dipchand AI, Dobbels F, Kirk R, Lund LH, Rahmel AO, et al.; International Society for Heart and Lung Transplantation. The Registry of the International Society for Heart and Lung Transplantation: thirtieth adult lung and heart-lung transplant report-2013; focus theme: age. J Heart Lung Transplant 2013;32: 965-978.